|
WO2021035068A2
|
|
Inhibitors of zika virus infection
|
|
WO2020087038A1
|
|
Zika virus immunogenic compositions
|
|
WO2019113169A2
|
|
HLA HOMOZYGOUS INDUCED PLURIPOTENT STEM CELL (iPSC) LIBRARIES
|
|
WO2018094241A1
|
|
Immunogenic composition for mers coronavirus infection
|
|
US2019328865A1
|
|
Immunogenic composition for mers coronavirus infection
|
|
US2017295219A1
|
|
Mobile file transfer methods and apparatus
|
|
WO2017173369A1
|
|
Biomakers and immunogenic compositions for filarial parasites
|
|
US2020231571A1
|
|
Substituted phenylpyrrolecarboxamides with therapeutic activity in hiv
|
|
US2018028658A1
|
|
Antibody-drug conjugates for reducing the latent hiv reservoir
|
|
WO2016130838A1
|
|
Porcine epidemic diarrhea virus immunogenic compositions
|
|
US2017273943A1
|
|
Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV
|
|
US2016002586A1
|
|
Megakaryocyte and platelet production from stem cells
|
|
US2016243201A1
|
|
Methods and compositions for increasing hepcidin expession using modified iron binding/releasing transferrin
|
|
AU2012205225A1
|
|
Ordered assembly of membrane proteins during differentiation of erythroblasts
|
|
EP2645854A2
|
|
Method of blood pooling and storage
|
|
AU2010328167A1
|
|
Use of transferrin in treatment of beta-thalassemias
|
|
AU2010310663A1
|
|
Antibodies, systems and methods for determining relative hemolytic index
|
|
AU2009305577A1
|
|
Immunoenhancer-linked oligomeric HIV vaccines
|
|
AU2007307254A1
|
|
Stabilized therapeutic small helical antiviral peptides
|
|
AU2006214698A1
|
|
Method for extraction and identification of nucleic acids
|
